[18F]fluoroalkyl analogues of the potent 5-HT1A antagonist WAY 100635: Radiosyntheses and in vivo evaluation
- 31 May 1996
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (4) , 487-490
- https://doi.org/10.1016/0969-8051(96)00026-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- N4-Unsubstituted N1-Arylpiperazines as High-Affinity 5-HT1A Receptor LigandsJournal of Medicinal Chemistry, 1995
- [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomographyLife Sciences, 1994
- Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brainEuropean Journal of Pharmacology, 1994
- Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouseEuropean Journal of Pharmacology, 1994
- In vivo binding of [123I]4‐(2′‐methoxy phenyl)‐1‐[2′‐(N‐2″‐pyridinyl)‐P‐iodobenzamido‐]ethyl‐piperazine, p‐MPPI, to 5‐HT1A receptors in rat brainSynapse, 1994
- The effect of tryptophan on brain 5‐HT function: A reviewHuman Psychopharmacology: Clinical and Experimental, 1994
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- The discovery and development of buspirone: A new approach to the treatment of anxietyMedicinal Research Reviews, 1990
- A rapid and efficient method for the fluoroalkylation of amines and amides. Development of a method suitable for incorporation of the short-lived positron emitting radionuclide fluorine-18The Journal of Organic Chemistry, 1987
- Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PATNature, 1983